BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

News | News By Subject | News by Disease News By Date | Search News

 News

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Cytos Biotechnology AG's Asthma Drug CYT003 Flunks Pivotal Phase 2b Study     4/14/2014   More...
FDA Orders Halozyme Therapeutics, Inc. (HALO) To Halt Pancreatic Cancer Study     4/11/2014   More...
Beware Gilead Sciences, Inc. (GILD), Merck & Co., Inc. (MRK)'s Hepatitis C Combo Pill Impresses In Phase 2 Trial     4/11/2014   More...
San Diego's Celladon Corporation Grabs FDA's “Breakthrough Therapy” Status for Gene Therapy     4/11/2014   More...
Seattle's Juno Therapeutics Pauses Trial After Patient Deaths     4/10/2014   More...
Idenix Pharmaceuticals, Inc. (IDIX)'s "Good" News Shows Hep C Drug Market Increasingly Murky For Investors     4/9/2014   More...
Puma Biotechnology (PBYI) Plummets On Disappointing Breast Cancer Drug Results     4/9/2014   More...
Pfizer Inc. (PFE) Continues Its Streak, Phase 2 Breast Cancer Results Wows Investors And Researchers     4/8/2014   More...
Halozyme Therapeutics, Inc. (HALO) Tanks As Enrollment In Phase 2 Pancreatic Cancer Study Is Halted; Stock Down -27.26% At 5:20PM ET (April 4, 2014)     4/4/2014   More...
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Shows Off Positive Phase 2 Alirocumab Data     4/2/2014   More...
PRANA Biotechnology (PRAN) Tanks As Lead Drug Fails Alzheimer's Study     4/1/2014   More...
Forest Laboratories, Inc. (FRX), Gedeon Richter Ltd. (RIG2.F) Tout Positive Phase 2b Bipolar Depression Data     3/31/2014   More...
Idera Pharmaceuticals, Inc. (IDRA)'s IMO-8400 Safe, Well Tolerated In Phase 2 Skin Disease Study     3/28/2014   More...
Pfizer Inc. (PFE)'s Experimental Anti-Cholesterol Drug Bococizumab Meets Main Study Goals     3/28/2014   More...
Novartis AG (NVS)'s Rare Lung Cancer Drug Ceritinib Shows Positive Response In Study     3/27/2014   More...
 Featured Stories
Rumor: Will Pfizer Inc. (PFE) Unveil A Breast Cancer Blockbuster At American Association for Cancer Research?     4/4/2014   More...
Popular Weight-Lifting Supplement May Slow Huntington Disease, Massachusetts General Hospital Study     2/11/2014   More...
Dawn of A New Sleep Drug at Merck & Co., Inc. (MRK)?     7/19/2011   More...
Cancer Trial Patients Take Rosy View of Likely Benefit, Oregon Health & Science University (OHSU) Study     1/28/2011   More...
Experimental Drug Panobinostat Shows Little Activity In MDS Patients, Sarah Cannon Research Institute Study     12/30/2010   More...
Cytokinetics, Inc. (CYTK) Drug Helps ALS Patients in Small Trial     12/13/2010   More...
American Society of Hematology: Novel Hodgkin Drug 'Dramatic' in Refractory Patients, City of Hope Study     12/7/2010   More...
American College of Rheumatology: Anti-IL17 Drug Misses Endpoint in RA Trial, Stanford University Study     11/11/2010   More...
American Association for Study of Liver Diseases: Early Study Shows HCV Vaccine Works, Scripps Clinic Study     11/3/2010   More...
American Association for Study of Liver Diseases: Rapid Response for Once-Daily Protease Inhibitor, University of North Carolina Study     11/3/2010   More...
American Academy of Ophthalmology: Glaucoma Drug Passes Early Clinical Test     10/21/2010   More...
Ceregene, Inc. Initiates a New Controlled Phase 2b Trial of Cere-120 for Parkinson's Disease     10/19/2010   More...
American Society for Bone and Mineral Research: Novel Drug Promising in Osteoporosis, University of Erlangen Study Reveals     10/19/2010   More...
American Academy of Ophthalmology: Retinoid Drug May Slow Dry AMD Progression     10/19/2010   More...
ESMO: New Agent Active in Advanced Ovarian Cancer, Dana-Farber Cancer Institute Study     10/15/2010   More...
ARCA biopharma Announces Screening Of First Patient In Phase 2B/3 Clinical Trial Evaluating Gencaro In Atrial Fibrillation     4/17/2014   More...
Islet Sciences Announces Positive 12-Week Phase 2 Clinical Results For SGLT2 Inhibitor Remogliflozin Etabonate     4/17/2014   More...
Galapagos NV (GLPG.BR) Release: GSK2586184 Met Primary Endpoint In Phase 2a Psoriasis Study     4/17/2014   More...
Nuvilex Could Obtain FDA Accelerated Approval After Phase 2b Clinical Trial     4/17/2014   More...
VentiRx Pharmaceuticals, Inc. Announces The Completion Of Patient Enrollment In Randomized, Placebo-Controlled Phase 2 Trial Of VTX-2337 In Combination With Pegylated-Liposomal Doxorubicin In Platinum-Resistant Ovarian Cancer     4/17/2014   More...
Akebia Therapeutics, Inc. (AKBA) Announces Completion Of Enrollment In Its Phase 2b Clinical Study Of AKB-6548     4/15/2014   More...
Theravance, Inc. (THRX) Announces Initiation Of Phase 2b Study With TD-4208, An Investigational LAMA For The Treatment Of COPD     4/15/2014   More...
Lexicon Pharmaceuticals, Inc. (LXRX)'s LX4211 Achieves Positive Results In Type 1 Diabetes Clinical Trial     4/14/2014   More...
Final Data From The Phase 2 COSMOS Study Of Janssen Research & Development's Once-Daily Simeprevir In Combination With Sofosbuvir Presented At The International Liver Congress™ 2014 Of The European Association For The Study Of The Liver (EASL)     4/14/2014   More...
Repros Therapeutics Inc. (RPRX) Fully Enrolls First Of Two Previously Announced Head To Head Studies Of Androxal® Versus The Leading Topical Testosterone Gel     4/14/2014   More...
GlycoMimetics, Inc. (GLYC) Announces Presentation Of Data On Rivipansel (GMI-1070) In Combination With Current FDA-Approved Treatment For Sickle Cell Disease     4/14/2014   More...
Merck & Co., Inc. (MRK)’s Investigational Chronic Hepatitis C Combination Therapy MK-5172/MK-8742 Demonstrates Antiviral Activity In Hard-To-Cure Patients With HCV Genotype 1 Infection     4/11/2014   More...
Nuvilex Engages Virusure To Establish Cell Banks For Phase 2b Clinical Trials In Pancreatic Cancer     4/10/2014   More...
BioLineRx Ltd. Announces Investigator-Initiated Study For Novel Chronic Myeloid Leukemia Treatment     4/10/2014   More...
GenKyoTex S.A. 's GKT137831 Found To Reverse Fibrosis And Improve Survival In A Model Of Persistent Lung Fibrosis     4/10/2014   More...
 More News
No News Posted on that date
 Career Tips
Emerging Job Search Trends In 2014     4/17/2014   More...
Hiring Managers Reveal The 15 BEST Words To Use On Your Resume     4/17/2014   More...
10 Interview Questions; The Good, Bad, And The Ugly     4/17/2014   More...
What Your Body Language Is Saying During The Interview     4/17/2014   More...
The 2 Stages Of Job Search Rejection     4/17/2014   More...
5 Resume Errors That Will Land You In The Trash     4/17/2014   More...
5 Rules Of Employment Follow-Up     4/3/2014   More...
3 Executive Resume Bloopers You’re Making Right Now     4/3/2014   More...
3 Secrets To Interview-Winning Cover Letters     4/3/2014   More...
6 Ways To Handle Irritating Colleagues     4/3/2014   More...
How To Find Out If You’re About To Get Laid Off     4/3/2014   More...
7 Deadly Mistakes Of Job Seekers     4/3/2014   More...
Inside The Hiring Manager’s Head At The Job Interview     3/20/2014   More...
Commonly Missed Job Interview Rules     3/20/2014   More...
Get The Crap Out Of Your Resume     3/20/2014   More...
Other News Sources
 

//-->